학술논문
Mezigdomide—A Novel Cereblon E3 Ligase Modulator under Investigation in Relapsed/Refractory Multiple Myeloma
Document Type
Review
Source
In: Cancers . (Cancers, March 2024, 16(6))
Subject
Language
English
ISSN
20726694